[Skip to Content]

Baldwin Breast Cancer Research lectures set for Oct. 4, 12

Baldwin Breast Cancer Research lectures set for Oct. 4, 12

SYRACUSE, N.Y.-- Upstate Medical University kicks off its recognition of Breast Cancer Awarness Month with two lectures on breast cancer. A nationally recognized expert on breast cancer research and a breast surgical oncologist who was instrumental in creating nationally accredited breast centers, will deliver the Endowed Carol M. Baldwin Breast Cancer Lectures this month/ The lectures are free and open to the public and will be of particular interest to scientists, physician-scientists, clinical investigators and breast cancer care providers.

- Carlos L. Arteaga, MD, will deliver the 2016 Annual Carol M. Baldwin Breast Cancer Research Lecture Tuesday, Oct. 4 from 11 a.m. to noon in Room 4114 of the Academic Building. A lunch reception will follow the presentation. Arteaga’s lecture is dedicated to breast cancer survivor Sally Bacon. The lecture is titled, “Mechanisms of resistance to endocrine therapy: insights from translational studies in breast cancer.”

“We are privileged to host one of the most accomplished breast cancer researchers, Dr. Carlos Arteaga,” said  Leszek Kotula, MD, PhD, associate director of the Basic and Translational Research Program at the Upstate Cancer Center, co-director of Upstate’s MD/PhD Program, and associate professor of urology and biochemistry and molecular biology. “Dr Arteaga's research accomplishments include defining the roles of IGF-I receptors and TGF beta in breast cancer progression and their use as therapeutic targets, defining mechanisms of drug resistance in antiestrogen therapy, and establishment of PI3K and HER2 as promising targets in breast cancer. Dr. Arteaga has designed and participated in numerous breast cancer clinical trials with significant impact on current and future patient treatments.”

Arteaga is the Donna S. Hall Chair in Breast Cancer Research and professor of medicine and cancer biology at Vanderbilt University Medical Center in Nashville, and director of the Center for Cancer Targeted Therapies and the Breast Cancer Program of the Vanderbilt-Ingram Cancer Center (VICC), where he also serves as associate director for Translational/Clinical Research.

He has more than 300 publications in the areas of signaling by growth factor receptors and oncogenes in breast tumor cells, development of targeted therapies and biomarkers of drug action and resistance, and investigator-initiated clinical trials in breast cancer. Since 2002, he has directed the NCI-funded Vanderbilt Breast Cancer SPORE where he co-leads several investigator-initiated clinical trials. He has chaired the AACR Special Conference ‘Advances in Breast Cancer Research’ since 2003 and has served as AACR co-chair of the annual San Antonio Breast Cancer Symposium since 2009. He served as the 2014-2015 President of the American Association for Cancer Research, the largest cancer research organization in the world.

- Anees B. Chagpar, MD, MSc, MPH, MA, MBA, FRSC©, FACS, will deliver the annual Carol Baldwin Breast Cancer Lecture at the Department of Surgery Grand Rounds, Wednesday, Oct. 12 from 8 to 9 am. in 2231 Weiskotten Hall. Her lecture is titled “The promise and perils of neoadjuvant therapy in the management of breast cancer.” It is dedicated to breast cancer survivor Stephanie Komanecky.

“The Baldwin Foundation provides Upstate Medical University and Central New York with a unique opportunity to bring in world class speakers in breast cancer management, like Dr. Chagpar,” said Scott P. Albert, MD, assistant professor of surgery, division chief of the Breast Care Center at UHCC and of Endocrine (Thyroid Surgery), and medical director of Upstate’s Breast Cancer Program. “Dr. Chagpar will discuss the role and challenges of giving chemotherapy before surgery, known as neoadjuvant therapy.”

Chagpar is director of The Breast Center at Smilow Cancer Hospital at Yale-New Haven, an associate professor in the Department of Surgery, Yale School of Medicine, the program director of the Interdisciplinary Breast Fellowship at Yale University and the assistant director for Global Oncology at Yale Comprehensive Cancer Center.

She built the first nationally accredited Breast Center at the University of Louisville’s James Graham Brown Cancer Center prior to being recruited to Yale in September 2010. At Yale, she led the university’s effort to become the first NCI-designated Comprehensive Cancer Center in the Northeast to have a nationally accredited breast center. She is a breast surgical oncologist who participates in investigator-initiated and cooperative group clinical trials, as well as translational and clinical research. She is the Breast Surgery Section Editor for UpToDate, a commonly used resource. She is passionate about global health and leadership in academic medicine, having most recently completed an MBA for executives with a focus on leadership in health care at Yale’s School of Management.

The Carol M. Baldwin Breast Cancer Research Fund Inc. sponsors two annual endowed lectureships focused on breast cancer developments. In addition, it annually supports five breast cancer research studies at Upstate with $250,000 in funding through its allocations program. Since 2002, the fund has awarded Upstate researchers more than $3 million to further their studies into the cause of breast cancer.

The Baldwin family dedicates their research grants and the endowed lectures in memory of women who have been affected by the disease

Caption: Carlos L. Arteaga, MD, and Anees B. Chagpar, MD, MSc, MPH, MA, MBA will deliver Carol M. Baldwin Breast Cancer lectures in October.

Top